Zobrazeno 1 - 10
of 512
pro vyhledávání: '"anti-fibrosis"'
Publikováno v:
Drug Design, Development and Therapy, Vol Volume 18, Pp 3255-3266 (2024)
Minmin Jiang,1,* Yongxia Xie,2,* Ping Wang,1 Mengyu Du,3 Ying Wang,4 Shuxun Yan1 1Department of Endocrinology, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, People’s Republic of China; 2Department of Resp
Externí odkaz:
https://doaj.org/article/e3f9a37072bb48bea42b8117ce8ea359
Autor:
Chunjing Guo, Wei Zhang, Qiaoyun Zhang, Yanguo Su, Xiaoya Hou, Qiang Chen, Huimin Guo, Ming Kong, Daquan Chen
Publikováno v:
Artificial Cells, Nanomedicine, and Biotechnology, Vol 51, Iss 1, Pp 170-179 (2023)
AbstractTumour development is not only an independent event of genetic mutation and overgrowth of tumour cells but is the result of a synergistic interaction between a malignant tumour and its surrounding tumour stromal microenvironment. In this pape
Externí odkaz:
https://doaj.org/article/54bdfd29264147e58766e6b53d80e46b
Autor:
Yunsheng Chen, Kun Chen, Shan Zhong, Jiaqiang Wang, Zhixi Yu, Xiyang Sun, Yue Wang, Yan Liu, Zheng Zhang
Publikováno v:
Advanced Science, Vol 11, Iss 7, Pp n/a-n/a (2024)
Abstract Hypertrophic scar (HS), which results from prolonged inflammation and excessive fibrosis in re‐epithelialized wounds, is one of the most common clinical challenges. Consequently, sophisticated transdermal transfersome nanogels (TA/Fu‐TS)
Externí odkaz:
https://doaj.org/article/ff2baf3801c5478e8c923d603c210c00
Publikováno v:
Journal of Inflammation Research, Vol Volume 16, Pp 1937-1948 (2023)
Xiuhui He, Siya Chen, Xiaohui Wang, Min Kong, Fangzheng Shi, Xiaoxuan Qi, Yuxin Xu Department of Ophthalmology, Second Affiliated Hospital of Anhui Medical University, Hefei, People’s Republic of ChinaCorrespondence: Yuxin Xu, Department of Ophthal
Externí odkaz:
https://doaj.org/article/f3771416c45344df8badca82feadb40b
Autor:
Weiwei Xu, Rui Peng, Siyu Chen, Congcong Wu, Xiaoxiao Wang, Ting Yu, Jiuying Jian, Ni Zhang, Siyang Zuo, Min Chen, Bing Guo, Lirong Liu
Publikováno v:
Pharmaceutical Biology, Vol 60, Iss 1, Pp 300-307 (2022)
Context Ranunculus ternatus Thunb (Ranunculaceae), (RTT) is used clinically for the treatment of tuberculosis or as tumour adjuvant therapy, but its potential effect on diabetic nephropathy (DN) has not been studied. Objective To investigate the effe
Externí odkaz:
https://doaj.org/article/1c3c2bc865ad46bc93aab0c7ed3098f0
Publikováno v:
Molecules, Vol 29, Iss 2, p 401 (2024)
The leaves of C. tiglium have been comprehensively researched for their structurally novel bioactive natural compounds, especially those with anti-schistosomiasis liver fibrosis activity, because ethyl acetate extract, which can be extracted from the
Externí odkaz:
https://doaj.org/article/462fe0fe5de2474e89fb74e4ac92b92a
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jiaxin Zhang, Ante Ou, Xueping Tang, Rong Wang, Yujuan Fan, Yuefei Fang, Yuge Zhao, Pengfei Zhao, Dongying Chen, Bing Wang, Yongzhuo Huang
Publikováno v:
Journal of Nanobiotechnology, Vol 20, Iss 1, Pp 1-17 (2022)
Abstract Dysregulated mucosal immune responses and colonic fibrosis impose two formidable challenges for ulcerative colitis treatment. It indicates that monotherapy could not sufficiently deal with this complicated disease and combination therapy may
Externí odkaz:
https://doaj.org/article/47ce4984abbe4285a6cff2d7d90eed41
Autor:
Wei Luo, Guang Xu, Zheng Song, Wenqing Mu, Jincai Wen, Siwen Hui, Jia Zhao, Xiaoyan Zhan, Zhaofang Bai, Xiaohe Xiao
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background: Inflammation and fibrosis are typical symptoms of non-alcoholic steatohepatitis (NASH), which is one of the most common chronic liver diseases. The cGAS-STING signaling pathway has been implicated in the progression of NASH, and targeting
Externí odkaz:
https://doaj.org/article/38e9d43dcb6d4d0889faa1e4e221ee9f
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Objective: To delineate the curative effect and safety of anti-fibrosis Chinese patent medicines (CPMs) combined with ursodeoxycholic acid (UDCA) for primary biliary cholangitis (PBC).Methods: A literature search was conducted using PubMed, Web of Sc
Externí odkaz:
https://doaj.org/article/02a59f5e9fca42b190e70c8cd6f49d26